Gary Kruppa is the CEO of MRM Proteomics. Gary and his team at MRM Proteomics Inc. work with the staff at the University of Victoria/Genome BC Protein Centre led by Prof. Christoph Borchers to develop MS assays for the quantitative analysis of proteins using LC-MRM/MS (PeptiQuant™ assays) and iMALDI methods. MRM Proteomics Inc. sells PeptiQuant™ assays as a service and has developed PeptiQuant™ kits for use in standardization of LC-MRM/MS workflows across laboratories worldwide. PeptiQuant™ kits are available both for LC-MRM/MS platform quality control and validation and for biomarker discovery and validation via Cambridge Isotope Laborarories, Inc, an its distributors worldwide. Gary received his Ph.D. in chemical physics from the California Institute of Technology.